Dr Reddys Laboratories Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Dr Reddys Laboratories Ltd RDY NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.37 -0.71% 51.89 51.42 52.4075 52.00 52.26 17:19:03
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,003 225,824 $ 52.02 $ 11,747,316 206,519 33.33 - 55.49
Last Trade Time Type Quantity Stock Price Currency
19:00:00 5,394 $ 51.89 USD

Dr Reddys Laboratories Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.61B 165.84M 165.84M $ 2.32B $ 216.00M 1.56 33.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.44M $ - 62.48% - -

more financials information »

Dr Reddys Laboratories News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week53.6453.9051.1252.23152,445-1.75-3.26%
1 Month52.8955.4951.1253.01185,220-1.00-1.89%
3 Months50.0055.4948.56551.92216,7881.893.78%
6 Months40.9755.4933.3346.59227,32910.9226.65%
1 Year37.6955.4933.3343.04199,69614.2037.68%
3 Years41.9155.4928.1336.91257,6009.9823.81%
5 Years58.7768.0028.1342.34286,132-6.88-11.71%

Dr Reddys Laboratories Description

With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, pharmaceutical services and active ingredients, and proprietary products and other, which make up most of the company's revenue at about 80%, 15%, and 3%, respectively. Most of the company's sales are based in the United States.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.